Information Provided By:
Fly News Breaks for February 27, 2018
SEM
Feb 27, 2018 | 07:03 EDT
As previously reported, JMP Securities analyst Peter Martin upgraded Select Medical to Market Perform from Underperform following the recent pullback in the shares after the company's Q4 adjusted EBITDA miss, as he believes the slide has made the shares fairly valued. While still concerned about the LTCH segment, he views Select Medical as the best-positioned LTCH operator to deal with patient criteria, Martin tells investors.
News For SEM From the Last 2 Days
There are no results for your query SEM